Loren Data's SAM Daily™

SAMDAILY.US - ISSUE OF JULY 25, 2026 SAM #9007
SOLICITATION NOTICE

A -- Battlefield Pain Management � Analgesic

Notice Date

7/23/2026 10:28:56 AM
 

Notice Type

Solicitation
 

NAICS

541714 — Research and Development in Biotechnology (except Nanobiotechnology)
 

Contracting Office

DEFENSE HEALTH AGENCY FORT DETRICK MD 21702 USA
 

ZIP Code

21702
 

Solicitation Number

HT942726RE009
 

Response Due

8/14/2026 9:00:00 AM
 

Archive Date

12/31/2026
 

Point of Contact

Shannon Lertora, Peter Mitchell
 

E-Mail Address

shannon.p.lertora.civ@health.mil, peter.d.mitchell8.civ@health.mil
(shannon.p.lertora.civ@health.mil, peter.d.mitchell8.civ@health.mil)
 

Small Business Set-Aside

NONE No Set aside used
 

Description

This Request for Prototype Proposal (RPP) is being issued under the authority of prototype Other Transaction Authority (pOTA) 10 U.S.C. 4022 by the Defense Health Agency Contracting Activity (DHACA), in support of the Defense Health Agency, Portfolio Acquisition Executive Medical Products (PAE MP), Warfighter Protection and Acute Care Project Management Office (WPAC PMO) located in Frederick, Maryland, at Fort Detrick. The requirement is for Analgesic Product for Battlefield Use. Please see the attached RPP and attachments for additional information. Amendment 0001 The purpose of Amendment 0001 is to: 1. Amend the Request for Prototype Proposal (RPP) as follows: - Extend the proposal due date from 30 July 2026 to 14 August 2026 (RPP Amendment 0001, page 1 and page 17). No additional questions/phone calls regarding the RPP will be accepted. - Update the word �drug� to �product� to align with the language (RPP Amendment 0001, page 2, section 1.1, third paragraph) - Clarify language regarding the Spend Plan (RPP Amendment 0001, page 13, section 3.5 Volume III: Administrative and Cost Volume, Attachment E � Cost Sheet Template with priced milestones, first paragraph). - Add additional Vendor requirements (RPP Amendment 0001, page 15, section 3.5 Volume III: Administrative and Cost Volume, Other Administrative Requirements). 2. Amend the RPP, Attachment A � Statement of Objectives (SOO) as follows: - Update the Revised Date (page 1). - Update language throughout to clarify the Government�s intent regarding drug versus product. - page 1, section 1. Purpose/Objective, second and third paragraphs - page 2, section 4 Objectives, second, third and fifth paragraphs - page 3, section 4 Objectives, first paragraph - page 5, Desirable prototype characteristics and performance, first paragraph - Revise the following Desirable prototype characteristics and performance: (2), (6), (9), and (13) (page 5 and page 6). - Revise the following Deliverables: Deliverable 3 and Deliverable 12 (page 7 and page 9, respectively). 3. Answer questions received from potential performers (see RPP Amendment 0001, Attachment 1). There are no other changes.
 

Web Link

SAM.gov Permalink
(https://sam.gov/workspace/contract/opp/31e3dea0a4874442b2ad847abac50974/view)
 

Place of Performance

Address: Frederick, MD 21702, USA

Zip Code: 21702

Country: USA
 

Record

SN07896978-F 20260725/260723230045 (samdaily.us)
 

Source

SAM.gov Link to This Notice
(may not be valid after Archive Date)

---

| FSG Index  |  This Issue's Index  |  Today's SAM Daily Index Page |